| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |